This page is part of the FHIR Specification (v3.0.2: STU 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4B R4 R3
Orders and Observations Work Group | Maturity Level: N/A | Ballot Status: Informative | Compartments: Device, Encounter, Patient, Practitioner, RelatedPerson |
Genetics example 3 (id = "example-genetics-3")
<Observation xmlns="http://hl7.org/fhir"> <id value="example-genetics-3"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><p> <b> Generated Narrative with Details</b> </p> <p> <b> id</b> : example-genetics-3</p> <p> <b> status</b> : final</p> <p> <b> code</b> : Further analysis <span> (Details )</span> </p> <p> <b> subject</b> : <a> Molecular Lab Patient ID: HOSP-23456</a> </p> <p> <b> issued</b> : 03/04/2013 3:30:10 PM</p> <p> <b> performer</b> : <a> Sequence Analysis Laboratory</a> </p> <p> <b> comment</b> : The EGFR p.L858R mutation has been associated with response to anti-EGFR therapy</p> <h3> Relateds</h3> <table> <tr> <td> -</td> <td> <b> Type</b> </td> <td> <b> Target</b> </td> </tr> <tr> <td> *</td> <td> derived-from</td> <td> <a> ObservationForGenetics profile example 1</a> </td> </tr> </table> </div> </text> <status value="final"/> <code> <text value="Further analysis"/> </code> <subject> <reference value="Patient/example"/> <display value="Molecular Lab Patient ID: HOSP-23456"/> </subject> <issued value="2013-04-03T15:30:10+01:00"/> <performer> <reference value="Practitioner/example"/> <display value="Sequence Analysis Laboratory"/> </performer> <comment value="The EGFR p.L858R mutation has been associated with response to anti-EGFR therapy"/> <related> <type value="derived-from"/> <target> <reference value="Observation/example-genetics-1"/> <display value="ObservationForGenetics profile example 1"/> </target> </related> </Observation>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.